Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 73097 

Counselors, National Center for Health 

Statistics, Centers for Disease Control 

and Prevention, 3311 Toledo Road, 

Hyattsville, Maryland 20782. 

Telephone: (301) 332–3467; Email: 

NMichaelis@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are sought for individuals 

who have the expertise and 

qualifications necessary to contribute to 

the accomplishment of the objective of 

the Board of Scientific Counselors, 

National Center for Health Statistics 

(BSC, NCHS) to provide advice and 

guidance on statistical and 

epidemiological research, data 

collection, and activities that support 

NCHS, such as: determinants of health; 

extent and nature of illness and 

disability, including life expectancy; 

incidence and prevalence of various 

acute and chronic illnesses/impairments 

and accidental injuries; infant and 

maternal morbidity and mortality; 

nutrition status; environmental, social, 

and other hazards affecting health 

status; health resources associated with 

physician and dental visits, 

hospitalizations, nursing, extended care 

facilities, home health agencies, and 

other health institutions; utilization of 

health care in a broad array of settings; 

trends in prices/costs and sources of 

payments; Federal, State, and local 

government expenditures for health care 

services; the relationship between 

demographic and socioeconomic 

characteristics and health 

characteristics; family formation, 

growth, and dissolution; new or 

improved methods for obtaining current 

data on the aforementioned factors; data 

security and confidentiality and 

comparability of data; and standardized 

means to collect information and 

statistics. 

Nominees will be selected based on 

expertise in fields associated with 

statistical, demographic, and 

epidemiological research, such as 

biostatistics/biometry, survey 

methodology and polling, sociology, 

reproductive health, minority health, 

nutrition, social and behavioral health 

sciences, and population-based public 

and environmental health; public health 

practice, e.g., State and local health data 

systems; operations research, health 

policy, and health services research, 

including health economics and 

econometrics; provision of health 

services, e.g., medicine, nursing, 

rehabilitation, other allied health care, 

and preventive medicine; health quality 

measurement and health indicators; 

health promotion; medical informatics; 

and data and health information 

security, storage, confidentiality, and 

dissemination. 

The Board makes recommendations 

about opportunities for NCHS programs 

to examine and employ new approaches 

to monitoring and evaluating key public 

health, health policy, and public policy 

changes. This includes automation, data 

modernization, and technological 

improvements to enhance data 

collection, analysis, access, and 

reporting capabilities of the Center. 

Members of the BSC, NCHS are 

responsible for maintaining awareness 

of emerging frameworks and 

technologies related to their individual 

disciplines and for providing updates 

and input, as appropriate, to the full 

Board through regular meetings and/or 

convening of workshops or symposia. 

The selection of members is based on 

candidates’ qualifications to contribute 

to accomplishing BSC, NCHS objectives 

(https://www.cdc.gov/nchs/about/ 

bsc.htm). Members may be invited to 

serve for up to four-year terms. 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on Federal workgroups or 

prior experience serving on a Federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Board 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning of and annually during their 

terms. The Centers for Disease Control 

and Prevention (CDC) reviews potential 

candidates for BSC, NCHS membership 

each year and provides a slate of 

nominees for consideration to the 

Secretary of HHS for final selection. 

HHS notifies selected candidates of 

their appointment near the start of the 

term in June, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

Candidates should submit the 

following items: 

■ Cover letter that includes a 

statement of interest for serving on the 

Board and the names of two 

professional references. Candidates may 

submit references from current HHS 

employees if they wish, but at least one 

reference must be submitted by a person 

not employed by an HHS agency (e.g., 

CDC, Health Resources and Services 

Administration, National Institutes of 

Health, Agency for Healthcare Research 

and Quality). 

■ Current resume/curriculum vitae, 

including complete contact information 

(telephone numbers, work and home 

postal mailing addresses, email address) 

in Microsoft Word or PDF format. 

■ Short biographical sketch, 

including the top 3–5 areas of expertise. 

Nominations may be submitted by the 

candidate or by the person/organization 

recommending the candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–20251 Filed 9–6–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–1984–14 and 

CMS–216–94] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 


ddrumheller on DSK120RN23PROD with NOTICES1
73098 Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by October 9, 2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Hospice Facility 

Cost Report Form; Use: Under the 

authority of sections 1815(a) and 1833(e) 

of the Social Security Act (the Act), 

CMS requires that providers of services 

participating in the Medicare program 

submit information to determine costs 

for health care services rendered to 

Medicare beneficiaries. CMS requires 

that providers follow reasonable cost 

principles under 1861(v)(1)(A) of the 

Act when completing the Medicare cost 

report (MCR). The regulations at 42 CFR 

413.20 and 413.24 require that providers 

submit acceptable cost reports on an 

annual basis and maintain sufficient 

financial records and statistical data, 

capable of verification by qualified 

auditors. In addition, regulations require 

that providers furnish such Information 

to the contractor as may be necessary to 

assure proper payment by the program, 

receive program payments, and satisfy 

program overpayment determinations. 

CMS regulations at 42 CFR 

413.24(f)(4) require that each hospice 

submit an annual cost report to their 

contractor in a standard American 

Standard Code for Information 

Interchange (ASCII) electronic cost 

report (ECR) format. A hospice submits 

the ECR file to contractors using a 

compact disk (CD), flash drive, or the 

CMS approved Medicare Cost Report Efiling (MCREF) portal, [URL: https://

mcref.cms.gov]. The instructions for 

submission are included in the hospice 

cost report instructions on page 43–3. 

CMS requires the Form CMS–1984–14 

to determine a hospice’s reasonable 

costs incurred in furnishing medical 

services to Medicare beneficiaries. CMS 

uses the Form CMS–1984–14 for rate 

setting; payment refinement activities, 

including developing a market basket; 

Medicare Trust Fund projections; and 

program operations support. 

Additionally, the Medicare Payment 

Advisory Commission (MedPAC) uses 

the hospice cost report data to calculate 

Medicare margins (a measure of the 

relationship between Medicare’s 

payments and providers’ Medicare 

costs) and analyze data to formulate 

Medicare Program recommendations to 

Congress. Form Number: CMS–1984–14 

(OMB control number: 0938–0758); 

Frequency: Yearly; Affected Public: 

Private Sector, Business or other forprofits, Not for profits institutions; 

Number of Respondents: 6,430; Total 

Annual Responses: 6,430; Total Annual 

Hours: 1,208,840. (For policy questions 

regarding this collection contact Duncan 

Gail at 410–786–7278.) 

2. Type of Information Collection: 

Extension of a currently approved 

collection; Title of Information 

Collection: Organ Procurement 

Organization Histocompatibility 

Laboratory Cost Report; Use: The Form 

CMS–216–94 cost report is needed to 

determine Organ Procurement 

Organization (OPO)/Histocompatibility 

Lab (HL) reasonable costs incurred in 

procuring and transporting organs for 

transplant into Medicare beneficiaries 

and reimbursement due to or from the 

provider. The reasonable costs of 

procuring and transporting organs 

cannot be determined for the fiscal year 

until the OPO/HL files its cost report 

and costs are verified by the Medicare 

contractor. During the fiscal year, an 

interim rate is established based on cost 

report data from the previous year. The 

OPO/HL bills the transplant hospital for 

services rendered. The transplant 

hospital pays interim payments, 

approximating reasonable cost, to the 

OPO/HL. The Form CMS–216–94 cost 

report is filed by each OPO/HL at the 

end of its fiscal year and there is a cost 

report settlement to take into account 

increases or decreases in costs. The cost 

report reconciliation and settlement take 

into consideration the difference 

between the total reasonable costs 

minus the total interim payments 

received or receivable from the 

transplant centers. Form Number: CMS– 

216–94 (OMB control number: 0938– 

0102); Frequency: Annually; Affected 

Public: Private Sector—Business or 

other for-profits; Number of 

Respondents: 95; Total Annual 

Responses: 95; Total Annual Hours: 

4,275. (For policy questions regarding 

this collection contact Luann Piccione 

at 410–786–5423.) 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–20236 Filed 9–6–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2023–E–2484] 

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; PLUVICTO 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or the Agency) has 

determined the regulatory review period 

for PLUVICTO and is publishing this 

notice of that determination as required 


ddrumheller on DSK120RN23PROD with NOTICES1